Simplify® Cervical Artificial Disc achieved the highest overall clinical success rate at both one- and two-levels compared to any other approved cervical disc
SAN DIEGO – April 6, 2021 – NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally ...
Simplify Cervical Artificial Disc provides NuVasive most clinically effective technology in the cervical total disc replacement (cTDR) procedure segment
Expands growth opportunities and further differentiates Company’s comprehensive portfolio across ACDF, PCF, and cTDR procedures
SAN DIEGO – February 24, 2021 ...
Sunnyvale, CA – December 16, 2020 – Simplify Medical, Inc., a privately-held company focused on cervical spinal disc arthroplasty and developer of the Simplify® Cervical Artificial Disc, today announced its first surgery following the recent FDA approval for 1-level use. The Simplify Disc is designed for MRI compatibility*, physiologic motion, and anatomical height-matching, with ...
Title: Simplify Medical Company Presentation
When: 11:00 AM Eastern Time
Who: David Hovda, Simplify Medical President & CEO